Royal UNIBREW A/S
18.1.2021 08:34:51 CET | Globenewswire | Press release
COMPANY ANNOUNCEMENT NO3/2021 – 18 JANUARY 2021
On 17 November 2020, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 38/2020 of 17 November 2020. The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (the Market Abuse Regulation - MAR) and the resulting delegated legislation. The share buy-back program is expected to be realized in the period from 18 November 2020 to 29 January 2021. The total share buy-back in the period will not exceed a market price of DKK 200 million.
The following transactions have been made under the program:
| Number of
Shares |
Average purchase price | Transaction value, DKK | |
| Accumulated, last announcement | 206,648 | 670.49 | 138,977,354.14 |
| 11 January 2021 | 8,000 | 658.49 | 5,267,947.20 |
| 12 January 2021 | 10,000 | 649.88 | 6,498,791.00 |
| 13 January 2021 | 9,298 | 641.47 | 5,964,425.25 |
| 14 January 2021 | 9,000 | 639.27 | 5,753,424.60 |
| 15 January 2021 | 10,000 | 629.16 | 6,291,559.00 |
| Accumulated under the program | 252,946 | 670.49 | 168,753,501.19 |
With the transactions stated above Royal Unibrew owns a total of 735,441 shares, corresponding to 1.5% of the share capital. The total amount of shares in the company is 49,350,000, including treasury shares.
For further information on this Announcement:
CFO Lars Vestergaard, tel (+45) 30 93 18 08
www.royalunibrew.com
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chery Group18.4.2026 15:54:00 CEST | Press release
iCAUR V27 Secures CATARC L3 Off-Road Certification, Solidifying Its New Energy Off-Road Capability with Robust Technology
Sanofi Winthrop Industrie18.4.2026 12:00:00 CEST | Press release
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
Organizing Committee of the 2026 Fujian Provincial Conference on the Development of Cultural and Tourism Economy18.4.2026 06:50:27 CEST | Press release
2026 Fujian Provincial Conference on Development of Cultural, Tourism Economy opens on Apr. 17 in Zhangzhou, SE China's Fujian
Evaxion17.4.2026 21:10:00 CEST | Press release
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
Zymeworks Inc.17.4.2026 21:00:00 CEST | Press release
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
